BRCA1 VUS:一种功能分析,用于区分致病性与良性变异,这些变异在乳腺癌临床诊断小组中被确定
Rita Adubeiro Lourenço1, Miguel Lança1, Octávia Monteiro Gil2
1ToxOmics, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa; 1150‑082 Lisbon, Portugal.
Molecular medicine reports
|May 26, 2023
概括
这项研究在乳腺癌患者中研究了一种未知意义的BRCA1变异 (VUS). 功能性测试表明这种VUS可能是良性的,显示出对DNA损伤的保护.
科学领域:
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 下一代测序 (NGS) 识别了许多遗传变异,包括未知意义的变异 (VUS),需要功能分类.
- 在遗传性乳腺癌中,BRCA1基因变异至关重要,了解VUS病原性对于临床管理至关重要.
研究的目的:
- 在乳腺癌患者中发现的BRCA1基因中的特定VUS (NM_007294.3:c.1067A>G) 的功能性特征.
- 评估这种VUS对DNA修复,基因组稳定性和亡途径的影响.
主要方法:
- 从VUS携带者和非携带者的外周淋巴细胞被隔离并接受NGS分析.
- 功能测试包括染色体异常,微核,彗星,γH2AX,卡斯帕斯和TUNEL测试在基因毒性挑战 (电离辐射或多克索鲁比辛) 后进行.
主要成果:
- 与对照组相比,微核和TUNEL测定表明VUS载体的DNA诱导损伤减少.
- 两组之间在染色体异常,彗星试验,γH2AX或酶试验方面没有发现显著差异.
结论:
- BRCA1 VUS (NM_007294.3:c.1067A>G) 似乎是良性的,因为携带者显示出对DNA损伤和染色体不稳定性的保护.
- 这些发现凸显了功能测试在VUS分类和告知乳腺癌风险评估中的重要性.
相关概念视频
Comparing Copy Number Variations and SNPs
17.8K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.8K
Genome-wide Association Studies-GWAS
13.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.7K


